Research Papers

25 of 12945 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Real-world analysis of teclistamab in 123 RRMM patients from Germany.
Riedhammer C; Bassermann F; Besemer B; Bewarder M; Brunner F; Carpinteiro A; Einsele H; Faltin J; Frenking J; Gezer D; Goldman-Mazur S; Hänel M; Hoegner M; Kortuem KM; Krönke J; Kull M; Leitner T; Mann C; Mecklenbrauck R; Merz M; Morgner A; Nogai A; Raab MS; Teipel R; Wäsch R; Rasche L.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patte…
Knauft J; Schenk T; Ernst T; Schnetzke U; Hochhaus A; La Rosée P; Birndt S.
Leukemia (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune di…
Semenzato G; Calabretto G; Teramo A; Gasparini VR; Rampazzo E; Barilà G; Zambello R.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
Loscocco GG; Gesullo F; Capecchi G; Atanasio A; Maccari C; Mannelli F; Vannucchi AM; Guglielmelli P.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice.
Huang L; Kondo Y; Cao L; Han J; Li T; Zuo B; Yang F; Li Y; Ma Z; Bai X; Jiang M; Ruan C; Xia L.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Regulation of tissue factor activity by interaction with the first PDZ domain of MAGI1.
Mohammad MA; Featherby S; Ettelaie C.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome.
Ho APT; Tjønnfjord E; Meyerdierks O; Brodin EE.
Thromb J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Factors influencing DVT formation in sepsis.
Wang L; Ma X; Chen Y; Gao S; Pan W; Chen J; Su L; He H; Long Y; Yin C; Zhou X; China National Critical Care Quality Control Centre Group (China-NCCQC).
Thromb J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clonal medicine targeting DNA damage response eradicates leukemia.
Toma MM; Karami A; Nieborowska-Skorska M; Chirtala KN; Pepek M; Hadzijusufovic E; Stoklosa T; Valent P; Skorski T.
Leukemia (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic impact of CEBPA mutational subgroups in adult AML.
Georgi JA; Stasik S; Kramer M; Meggendorfer M; Röllig C; Haferlach T; Valk P; Linch D; Herold T; Duployez N; Taube F; Middeke JM; Platzbecker U; Serve H; Baldus CD; Muller-Tidow C; Haferlach C; Koch S; Berdel WE; Woermann BJ; Krug U; Braess J; Hiddemann W; Spiekermann K; Boertjes EL; Hills RK; Burnett A; Ehninger G; Metzeler K; Rothenberg-Thurley M; Dufour A; Dombret H; Pautas C; Preudhomme C; Fenwarth L; Bornhäuser M; Gale R; Thiede C.
Leukemia (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
Abdallah NH; Lakshman A; Kumar SK; Cook J; Binder M; Kapoor P; Dispenzieri A; Gertz MA; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Lin Y; Kourelis T; Warsame R; Bergsagel L; Rajkumar SV.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an e…
Wu X; Ma X; Song T; Liu J; Sun Y; Wu D.
Ann Hematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coag…
Totoki T; Makino Y; Yamakawa K; Koami H; Wada T; Ito T; Iba T.
Unknown Journal
Published: 2024
4/6 Transparent
Registered Funding Declared
Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Fac…
Al-Awadhi A; Marouf R; Jadaon MM; Al-Awadhy MM.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
CAR-T Cell Therapy for Follicular Lymphomas.
Testa U; D'Alò F; Pelosi E; Castelli G; Leone G.
Unknown Journal
Published: 2024
2/6 Transparent
Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics…
Bibas M.
Unknown Journal
Published: 2024
2/6 Transparent
How We Prevented an anti-P1 Mediated Hemolytic Transfusion Reaction.
Martini T; Biguzzi R; Francesconi I; Lelli S; Currà MF; Borsellino B.
Mediterr J Hematol Infect Dis (Unknown)
Published: 2024
2/6 Transparent
Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia.
Yang K; Liu X; Peng W; Hua F; Li L; Chen K; Zhang J; Luo S; Li W; Ding Y; Chen J; Xiao J.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Safety of Bronchoalveolar Lavage in Hematological Patients with Thrombocytopenia. A Retrospective Cohort Study.
Gur I; Tounek R; Dotan Y; Evgrafov EV; Rakedzon S; Fuchs E.
Mediterr J Hematol Infect Dis (Unknown)
Published: 2024
2/6 Transparent
Oxidative stress in acute pulmonary embolism: emerging roles and therapeutic implications.
Yang J; Xu J; Xu S; Fan Z; Zhu C; Wan J; Yang J; Xing X.
Thromb J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU.
Fischer K; Kenet G; Kurnik K; Carcao M; Oldenburg J; Stamm-Mikkelsen T; Cid Haro AR; Koskenvuo M; Blatny J; Königs C.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Sockel K; Götze K; Ganster C; Bill M; Georgi JA; Balaian E; Aringer M; Trautmann-Grill K; Uhlig M; Bornhäuser M; Haase D; Thiede C.
Unknown Journal
Published: 2024
2/6 Transparent
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a precl…
Hänel G; Schönle A; Neumann AS; Nixdorf D; Philipp N; Sponheimer M; Leutbecher A; Emhardt AJ; Magno G; Bücklein V; Eckmann J; Dunshee D; Kramar V; Korfi K; Colombetti S; Umaña P; Klein C; Subklewe M.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.
Short NJ; Jabbour E; Jain N; Senapati J; Nasr L; Haddad FG; Li Z; Hsiao YC; Yang JJ; Pemmaraju N; Ohanian M; Wierda WG; Montalban-Bravo G; Borthakur G; Han L; Xiao L; Huang X; Abramova R; Zhao M; Garris R; Konopleva M; Ravandi F; Kantarjian H.
Blood Adv (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A.
Blood Adv (Unknown)
Published: 2024
3/6 Transparent
Funding Declared